STOCK TITAN

Senseonics Holdings Inc - SENS STOCK NEWS

Welcome to our dedicated news page for Senseonics Holdings (Ticker: SENS), a resource for investors and traders seeking the latest updates and insights on Senseonics Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Senseonics Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Senseonics Holdings's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.81%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.04%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.19%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.5%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.55%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.55%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
80.38%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Senseonics Holdings Inc

NYSE:SENS

SENS Rankings

SENS Stock Data

255.25M
507.34M
6.4%
12.45%
7.88%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Germantown

About SENS

senseonics, inc. is a medical device startup company in germantown, maryland, usa (near washington, dc) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. utilizing breakthrough fluorescence sensing technology, the senseonics continuous glucose monitoring ("cgm"​) system is being designed to be the first fully implantable cgm that is highly accurate and stable throughout its long sensor life. the system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.